科拓生物：公司在呼和浩特市建设的新产能已满足投产条件，近期已投入运营并开始试生产

Core Viewpoint - The company has confirmed that its new production capacity for probiotic products is operational and will be gradually released based on customer orders, ensuring that it meets market demand without causing oversupply [1] Group 1: Production Capacity - The overall production capacity of the company's probiotic products is currently high, with the utilization rate remaining at a satisfactory level [1] - The new production capacity in Hohhot, Inner Mongolia, has met the conditions for operation and has recently commenced trial production [1] Group 2: Market Demand and Supply - The company plans to release the new production capacity in an orderly manner, in batches, according to customer order situations [1] - There is an emphasis on avoiding redundancy in production that could negatively impact product pricing [1]